Financials S2Medical AB

Equities

S2M

SE0011725084

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:29:59 2024-06-07 am EDT 5-day change 1st Jan Change
0.036 SEK -25.00% Intraday chart for S2Medical AB -32.46% -40.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 344.5 107.1 90.36 79.02 22.09
Enterprise Value (EV) 1 310.3 93.12 66.05 69.75 18.37
P/E ratio -16.1 x -5.81 x -6.25 x -3.88 x -0.55 x
Yield - - - - -
Capitalization / Revenue 84.1 x 19.1 x 3.28 x 7.21 x 3.59 x
EV / Revenue 75.8 x 16.6 x 2.4 x 6.36 x 2.98 x
EV / EBITDA -30.5 x -5.34 x -4.71 x -3.72 x -0.7 x
EV / FCF -29,611,292 x -6,982,820 x -9,896,917 x -9,160,900 x -1,121,484 x
FCF Yield -0% -0% -0% -0% -0%
Price to Book 7.91 x 4.26 x 3.61 x 5.38 x 3.13 x
Nbr of stocks (in thousands) 11,295 11,295 11,295 15,052 32,492
Reference price 2 30.50 9.480 8.000 5.250 0.6800
Announcement Date 4/25/19 4/24/20 4/26/21 4/26/22 5/10/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 1.978 4.095 5.599 27.53 10.96 6.159
EBITDA 1 -4.573 -10.17 -17.45 -14.03 -18.73 -26.37
EBIT 1 -5.224 -10.61 -18.33 -14.94 -19.84 -27.69
Operating Margin -264.07% -259.04% -327.45% -54.25% -180.99% -449.53%
Earnings before Tax (EBT) 1 -5.377 -10.73 -18.44 -15.01 -20.08 -29.46
Net income 1 -5.377 -10.73 -18.44 -15.01 -20.08 -29.46
Net margin -271.81% -262.07% -329.26% -54.52% -183.21% -478.23%
EPS - -1.899 -1.632 -1.279 -1.354 -1.239
Free Cash Flow - -10.48 -13.34 -6.674 -7.614 -16.38
FCF margin - -255.92% -238.18% -24.24% -69.47% -265.95%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/7/18 4/25/19 4/24/20 4/26/21 4/26/22 5/10/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 2.92 34.2 14 24.3 9.27 3.72
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -10.5 -13.3 -6.67 -7.61 -16.4
ROE (net income / shareholders' equity) -106% -42.1% -53.7% -51.9% -84.3% -271%
ROA (Net income/ Total Assets) -37.1% -22% -28.7% -25.9% -34.9% -63%
Assets 1 14.49 48.77 64.19 57.84 57.61 46.78
Book Value Per Share - 3.860 2.220 2.220 0.9800 0.2200
Cash Flow per Share - 3.230 1.370 1.700 0.6300 0.1100
Capex - - 0.64 0.06 0.19 0.11
Capex / Sales - - 11.52% 0.23% 1.71% 1.78%
Announcement Date 5/7/18 4/25/19 4/24/20 4/26/21 4/26/22 5/10/23
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. S2M Stock
  4. Financials S2Medical AB